Home > Insider Trading > Filing (0001209191-13-017951)

Filing Details

Accession Number:: 0001209191-13-017951
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-03-21 19:22:56
Reporting Period:: 2013-03-19

Filing Date:: 2013-03-21
Accepted Time:: 2013-03-21 18:22:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1443669	Proto Labs Inc	PRLB	Fabricated Structural Metal Products (3440)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1542472	A. Bradley Cleveland	5540 Pioneer Creek Drive Maple Plain MN 55359	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-03-19	1,107	$45.11	93,393	No	4	S	Indirect	By JMC Irrevocable Gift Trust
Common Stock	Disposition	2013-03-19	1,107	$45.11	93,393	No	4	S	Indirect	By KEC Irrevocable Gfit Trust
Common Stock	Disposition	2013-03-19	1,298	$45.11	674,884	No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
Common Stock	Disposition	2013-03-19	52,436	$45.51	40,957	No	4	S	Indirect	By JMC Irrevocable Gift Trust
Common Stock	Disposition	2013-03-19	52,436	$45.51	40,957	No	4	S	Indirect	By KEC Irrevocable Gfit Trust
Common Stock	Disposition	2013-03-19	61,593	$45.51	613,291	No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
Common Stock	Disposition	2013-03-19	21,458	$46.94	19,499	No	4	S	Indirect	By JMC Irrevocable Gift Trust
Common Stock	Disposition	2013-03-19	21,458	$46.94	19,499	No	4	S	Indirect	By KEC Irrevocable Gfit Trust
Common Stock	Disposition	2013-03-19	25,204	$46.94	588,087	No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
Common Stock	Disposition	2013-03-20	19,499	$45.88	0	No	4	S	Indirect	By JMC Irrevocable Gift Trust
Common Stock	Disposition	2013-03-20	19,499	$45.88	0	No	4	S	Indirect	By KEC Irrevocable Gfit Trust
Common Stock	Disposition	2013-03-20	22,905	$45.88	565,182	No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
Common Stock	Disposition	2013-03-20	200,000	$45.82	365,182	No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By JMC Irrevocable Gift Trust
No	4	S	Indirect	By KEC Irrevocable Gfit Trust
No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
No	4	S	Indirect	By JMC Irrevocable Gift Trust
No	4	S	Indirect	By KEC Irrevocable Gfit Trust
No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
No	4	S	Indirect	By JMC Irrevocable Gift Trust
No	4	S	Indirect	By KEC Irrevocable Gfit Trust
No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
No	4	S	Indirect	By JMC Irrevocable Gift Trust
No	4	S	Indirect	By KEC Irrevocable Gfit Trust
No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust
No	4	S	Indirect	By Bradley A. Cleveland Declaration Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	100,000	Indirect	By JK Cleveland Irrevocable Trust

Footnotes

Sales effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted on February 15, 2013 by the Bradley A. Cleveland Declaration Trust (the "BAC Trust"), JMC 2011 Irrevocable Gift Trust (the "JMC Trust") and KEC 2011 Irrevocable Gift Trust (the "KEC Trust") and (collectively referred to as the "Trusts"). Pursuant to the terms of the Trading Plan, the allocation of shares to be sold is approximately 37% for the BAC Trust, 31.5% for the JMC Trust and 31.5% for the KEC Trust except as provided in footnote 7 below. The sales reflected on this Form 4 conclude the transactions contemplated by the Trading Plan.
Reflects the weighted average price of 3,512 shares of common stock of Proto Labs, Inc. sold by the Trusts in multiple transactions on March 19, 2013 with sale prices ranging from $45.10 to $45.16 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
The reporting person has no voting rights over the shares and disclaims beneficial ownership.
Reflects the weighted average price of 166,465 shares of common stock of Proto Labs, Inc. sold by the Trusts in multiple transactions on March 19, 2013 with sale prices ranging from $45.19 to $46.19 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 68,120 shares of common stock of Proto Labs, Inc. sold by the Trusts in multiple transactions on March 19, 2013 with sale prices ranging from $46.27 to $47.23 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 61,903 shares of common stock of Proto Labs, Inc. sold by the Trusts in multiple transactions on March 20, 2013 with sale prices ranging from $45.70 to $45.97 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Reflects the weighted average price of 200,000 shares of common stock of Proto Labs, Inc. sold by the BAC Trust in multiple transactions on March 20, 2013 with sale prices ranging from $45.45 to $46.36 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
These shares are held indirectly by a trust for the benefit of the reporting person's children. The reporting person is a trustee of the trust. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest in them.